tm logo
SMARXT
Live/Pending
NOTICE OF ALLOWANCE - ISSUED

issued

on 03 Dec 2024

Last Applicant/ Owned by

10573 W. Pico Blvd, #58

Los Angeles

CA

90064

Serial Number

98426370 filed on 28th Feb 2024

Registration Number

N/A

Correspondent Address

Sheila R. Gibson

Sheila R. Gibson Aura IP Law

Lakewood, CA 90712

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

SMARXT

scientific research in the field of oncology; scientific research in the field of immuo-dysregulated diseases; development of pharmaceutical preparations and medicines for the treatment of cancer; development of pharmaceutical preparations and medicines for the treatment of immuno-dysregulated diseases; clinical research in the field of oncology; clinical research in the field of immuo-dysregulate Read More

Classification Information


Class [042]
Computer & Software Services & Scientific Services


scientific research in the field of oncology; scientific research in the field of immuo-dysregulated diseases; development of pharmaceutical preparations and medicines for the treatment of cancer; development of pharmaceutical preparations and medicines for the treatment of immuno-dysregulated diseases; clinical research in the field of oncology; clinical research in the field of immuo-dysregulated diseases; research and development services in the field of anti-cancer preparations; research and development services in the field of preparations for treating immuno-dysregulated diseases; design, engineering, research, development and testing services in the field of oncology; design, engineering, research, development and testing services in the field of immuno-dysregulated diseases; providing information regarding medical research relating to oncology; providing information regarding medical research relating to immuno-dysregulated diseases


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [005]
Pharmaceutical Products


anti-cancer preparations; anti-cancer drugs; compounds for treating cancer; pharmaceuticals for the treatment of cancer; pharmaceutical products for the treatment of cancer; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical compositions for the treatment of cancer; pharmaceutical drugs for the treatment of cancer; pharmaceutical preparations for human use for the treatment of cancer; pharmaceutical preparations and substances for the treatment of treatment-resistant cancers biological preparations for the treatment of cancer; biological preparations for medical purposes for the treatment of cancer; medical preparations for the treatment of cancer; medicinal preparations and substances for the treatment of cancer; medicines for human purposes for the treatment of cancer; injectable pharmaceuticals for the treatment of cancer; compounds for treating resistant cancers; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations for use in chemotherapy; anti-tumor preparations; anti-tumor drugs; tumor suppressing agents; pharmaceutical preparations for suppressing tumors; preparations for treating malignant tumors; medicines for the treatment of gastrointestinal diseases; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; pharmaceutical preparations for treating gastrointestinal disorders


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 98426370

Mark Type

No Service Mark

Attorney Docket Number

No IMX-013UST

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Status DateAction Taken
03rd Dec 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
22nd Oct 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
22nd Oct 2024PUBLISHED FOR OPPOSITION
02th Oct 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
17th Sep 2024APPROVED FOR PUB - PRINCIPAL REGISTER
16th Sep 2024ASSIGNED TO EXAMINER
10th Jul 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
29th Feb 2024NEW APPLICATION ENTERED